X4 Pharmaceuticals Inc (XFOR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 55,699 | 99,216 | 121,718 | 81,787 | 78,708 |
| Marketable Securities | 46,361 | 15,000 | N/A | N/A | N/A |
| Receivables | 1,710 | 562 | 1,152 | 747 | 917 |
| Inventories | 2,817 | 0 | N/A | N/A | N/A |
| TOTAL | $112,175 | $122,076 | $128,677 | $87,878 | $83,307 |
| Non-Current Assets | |||||
| PPE Net | 776 | 745 | 1,104 | 1,514 | 1,237 |
| Intangibles | 27,351 | 17,351 | 17,351 | 17,351 | 27,109 |
| Other Non-Current Assets | 6,145 | 7,086 | 8,454 | 10,433 | 11,218 |
| TOTAL | $34,272 | $25,182 | $26,909 | $29,298 | $39,564 |
| Total Assets | $146,447 | $147,258 | $155,586 | $117,176 | $122,871 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | 1,315 | 795 | N/A |
| Accounts payable and accrued liabilities | 8,621 | 8,947 | 7,777 | 4,283 | 3,144 |
| Accrued Expenses | 23,005 | 12,816 | 12,034 | 7,870 | 8,018 |
| TOTAL | $32,877 | $22,862 | $22,324 | $14,023 | $11,948 |
| Non-Current Liabilities | |||||
| Long Term Debt | 75,425 | 54,570 | 32,304 | 33,139 | 33,178 |
| Other Non-Current Liabilities | 15,996 | 18,727 | 26,907 | 5,602 | 4,946 |
| TOTAL | $91,421 | $73,297 | $59,211 | $38,741 | $38,124 |
| Total Liabilities | $124,298 | $96,159 | $81,535 | $52,764 | $50,072 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 5,783 | 5,592 | 4,070 | 1,026 | 579 |
| Common Shares | 171 | 167 | 122 | 28 | 16 |
| Retained earnings | -515,355 | -477,905 | -376,738 | -282,871 | -194,175 |
| Other shareholders' equity | -122 | -119 | -119 | -119 | -119 |
| TOTAL | $22,149 | $51,099 | $74,051 | $64,412 | $72,799 |
| Total Liabilities And Equity | $146,447 | $147,258 | $155,586 | $117,176 | $122,871 |